How to Navigate the Catalog by Mechanism: From Receptors to Bioenergetics
Research-Only: Informational guidance for experimental planning.
Start by defining the primary readout—endocrine (GH pulse metrics), structural (migration/ECM), metabolic (incretin signaling, AMPK), or bioenergetic (mitochondrial potential, ROS, ATP). For endocrine models, long-acting GHRH analogs alter GH/IGF-1 kinetics with preserved pulsatility (PMID: 17018654). For recovery and matrix studies, cytoskeletal and angiogenic markers respond to peptides that modulate FAK/paxillin and eNOS (PMC: PMC8275860).
In metabolic investigations, GLP-1R agonism raises cAMP to drive PKA/Epac and context-specific outcomes in beta cells and CNS nuclei (PMID: 17306374; PMC: PMC10691799). For mitochondrial longevity, MOTS-c engages AMPK and SS-31 stabilizes cardiolipin to support oxidative phosphorylation; NAD+ level management interfaces with sirtuin deacetylation (PMID: 25738459; PMC: PMC7334473; PMC: PMC6206880).
Map peptides to targets, align assays to endpoints, and document conditions to enhance reproducibility. Browse the full catalog.

Methodological Notes. To contextualize mechanistic observations, laboratories typically
report experimental temperature, buffer composition, biological replicates, and blinding/randomization
practices for image analysis and Western quantification. Where possible, orthogonal corroboration is
included: for example, receptor pharmacology by radioligand binding or BRET assays combined with
downstream second messengers; structural endpoints by both live-cell imaging and fixed immunostaining;
and bioenergetics readouts by oxygen consumption/ECAR coupled to targeted metabolomics. These practices
increase reproducibility and allow meaningful comparison across peptide classes and batches in research-only
settings (PMC: PMC7350483).
Statistics & Reporting. Typical analyses include power calculations, pre-registered endpoints,
and multiple-comparisons adjustments for families of tests. Effect-size reporting (Cohen’s d or Hedges’ g),
confidence intervals, and transparent outlier policies enable precise interpretation of receptor- or
mitochondria-targeted peptide experiments. Collectively, these design elements improve the signal-to-noise
ratio in bench studies and inform subsequent assay selection. Browse the full catalog.
